Literature DB >> 18829326

Intraventricular ganglioglioma.

Erik F Hauck1, Lisa Vu, Gerald A Campbell, Haring J Nauta.   

Abstract

Gangliogliomas are mixed tumors consisting of both glial elements and differentiated neurons. Although any part of the central nervous system can be affected, little is known about intraventricular gangliogliomas. A patient with a ganglioglioma is presented in the previously unreported location of the anterior third ventricle at the foramen of Monro, mimicking a colloid cyst. We review all other reported cases of intraventricular ganglioglioma (n=6) to characterize this entity. Intraventricular gangliogliomas typically affect younger patients with female predominance (male:female, 2:5; median age 25 years). Symptoms occur secondary to obstruction of physiological cerebrospinal fluid circulation. Complete surgical resection with re-establishment of cerebrospinal fluid drainage is the goal of treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18829326     DOI: 10.1016/j.jocn.2007.09.013

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  4 in total

1.  Ganglioglioma in the Third Ventricle: A Case Report and Literature Review.

Authors:  Nayuta Higa; Hajime Yonezawa; Tatsuki Oyoshi; Tsubasa Hiraki; Hirofumi Hirano; Kazunori Arita
Journal:  NMC Case Rep J       Date:  2016-05-19

2.  Rosai-Dorfman disease mimicking subdural hematoma: a case report.

Authors:  Zhiqiang Zhou; Si Jian; Xu Zhao
Journal:  J Int Med Res       Date:  2022-03       Impact factor: 1.671

3.  Intraventricular ganglioglioma with dissemination of cerebrospinal fluid.

Authors:  Patricia Pitta de Abreu; Bernardo Carvalho Muniz; Nina Ventura; Emerson Gasparetto; Edson Marchiori
Journal:  Radiol Bras       Date:  2018 Jul-Aug

4.  Ganglioglioma of the adenohypophysis mimicking pituitary adenoma: A case report and review of the literature.

Authors:  Yuan Hong; Yuanjian Fang; Qun Wu; Jianmin Zhang; Yongjie Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.